UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001925
Receipt number R000002341
Scientific Title Effects of ghrelin administration after total gastrectomy in patients with gastric cancer: A prospective randomized placebo-controlled phase II study
Date of disclosure of the study information 2009/05/01
Last modified on 2009/04/30 23:25:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of ghrelin administration after total gastrectomy in patients with gastric cancer: A prospective randomized placebo-controlled phase II study

Acronym

Effects of ghrelin administration after total gastrectomy in patients with gastric cancer: A prospective randomized placebo-controlled phase II study

Scientific Title

Effects of ghrelin administration after total gastrectomy in patients with gastric cancer: A prospective randomized placebo-controlled phase II study

Scientific Title:Acronym

Effects of ghrelin administration after total gastrectomy in patients with gastric cancer: A prospective randomized placebo-controlled phase II study

Region

Japan


Condition

Condition

Gastric cancer patients who underwent total gastrectomy.

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To elucidate whether exogenous ghrelin administration prevents postoperative body weight loss by improving appetite and oral food intake in patients with gastric cancer after undergoing total gastrectomy.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

Food intake calories (during 10-days ghrelin administration)

Key secondary outcomes

appetite VAS, postoperative body weight, postoperative BMI (during 10-days ghrelin administration)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Intervention A; ghrelin group (+)
ghrelin administration
postoperative 10-days
twice a day
before breakfast and before dinner

Interventions/Control_2

Intervention B; placebo group (-)
saline administration
postoperative 10-days
twice a day
before breakfast and before dinner

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

The inclusion criteria were as follows: 1) adenocarcinoma of the stomach confirmed by histopathological examination, 2) preoperative clinical staging with less than stage II (UICC TNM stage classification), 3) curative surgical treatment (R0), i.e., TG with D1 or D2 lymph node dissection, and 4) Age >20 and <80 years.

Key exclusion criteria

The exclusion criteria were the presence of any of the following; 1) cardiopulmonary, liver or renal dysfunction, 2) active dual malignancy, 3) pregnancy, 4) past history of gastrointestinal surgery, 5) postoperative complications after TG that could affect oral food intake, such as anastomotic leakage, pancreatitis and ileus.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuichiro Doki

Organization

Osaka University School of Medicine

Division name

Gastroenterological Surgery

Zip code


Address

2-2 Yamadaoka Suita City Osaka

TEL

06-6879-3251

Email



Public contact

Name of contact person

1st name
Middle name
Last name Shuji Takiguchi

Organization

Osaka University School of Medicine

Division name

Gastroenterological Surgery

Zip code


Address


TEL

06-6879-3251

Homepage URL


Email



Sponsor or person

Institute

Osaka University School of Medicine Gastroenterological Surgery

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2005 Year 04 Month 19 Day

Date of IRB


Anticipated trial start date

2006 Year 06 Month 01 Day

Last follow-up date

2008 Year 06 Month 01 Day

Date of closure to data entry

2008 Year 06 Month 01 Day

Date trial data considered complete

2008 Year 06 Month 01 Day

Date analysis concluded

2008 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2009 Year 04 Month 30 Day

Last modified on

2009 Year 04 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002341


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name